Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease

Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease

Reduced Brain-Derived Neurotrophic Factor (BDNF) levels have been described in a number of patho-physiological conditions, most notably, in Huntington's disease (HD), a progressive neurodegenerative disorder. Since BDNF is also produced in blood, we have undertaken the measurement of its periph...

Full description

Bibliographic Details
Main Authors:	Zuccato, Chiara, Marullo, Manuela, Vitali, Barbara, Tarditi, Alessia, Mariotti, Caterina, Valenza, Marta, Lahiri, Nayana, Wild, Edward J., Sassone, Jenny, Ciammola, Andrea, Bachoud-Lèvi, Anne Catherine, Tabrizi, Sarah J., Di Donato, Stefano, Cattaneo, Elena
Format:	Online
Language:	English
Published:	Public Library of Science 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155522/

Similar Items

Pitfalls in the detection of cholesterol in Huntington’s disease models
by: Marullo, Manuela, et al.
Published: (2012)

Defining the role of the Bcl-2 family proteins in Huntington's disease
by: Sassone, J, et al.
Published: (2013)

Abnormal peripheral chemokine profile in Huntington’s disease
by: Wild, Edward, et al.
Published: (2011)

Counterfactual Thinking Deficit in Huntington’s Disease
by: Solca, Federica, et al.
Published: (2015)

JAK/STAT Signalling in Huntington’s Disease Immune Cells
by: Träger, Ulrike, et al.
Published: (2013)

Forkhead Transcription Factor FOXO3a Levels Are Increased in Huntington Disease Because of Overactivated Positive Autofeedback Loop*
by: Kannike, Kaja, et al.
Published: (2014)

Atypical Parkinsonism Revealing a Late Onset, Rigid and Akinetic Form of Huntington's Disease
by: Ciammola, A., et al.
Published: (2011)

Low Anaerobic Threshold and Increased Skeletal Muscle Lactate Production in Subjects with Huntington's Disease
by: Ciammola, Andrea, et al.
Published: (2011)

George Huntington: a legacy of inquiry, empathy and hope
by: Wexler, Alice, et al.
Published: (2016)

Targets for future clinical trials in Huntington's disease: What's in the pipeline?
by: Wild, Edward J, et al.
Published: (2014)

Awareness of Memory Deficits in Early Stage Huntington's Disease
by: Cleret de Langavant, Laurent, et al.
Published: (2013)

Huntington’s Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy
by: Sari, Youssef
Published: (2011)

Alloimmunisation to Donor Antigens and Immune Rejection Following Foetal Neural Grafts to the Brain in Patients with Huntington's Disease
by: Krystkowiak, Pierre, et al.
Published: (2007)

Stability of white matter changes related to Huntington’s disease in the presence of imaging noise: a DTI study
by: Müller, Hans-Peter, et al.
Published: (2011)

How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease
by: Schramm, Catherine, et al.
Published: (2015)

Huntington's Disease: The Most Curable Incurable Brain Disorder?
by: Wild, Edward J.
Published: (2016)

Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington’s Disease
by: Rodrigues, Filipe Brogueira, et al.
Published: (2016)

Psychogenic non-epileptic seizures in early Huntington's disease
by: Rodrigues, Filipe Brogueira, et al.
Published: (2016)

Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease
by: Giampà, Carmela, et al.
Published: (2013)

Correction: Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease
by: Giampà, Carmela, et al.
Published: (2016)

Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease
by: Rodrigues, Filipe Brogueira, et al.
Published: (2016)

Brain Derived Neurotrophic Factor (BDNF) Expression Is Regulated by MicroRNAs miR-26a and miR-26b Allele-Specific Binding
by: Caputo, Viviana, et al.
Published: (2011)

Times of Crisis : Success or Decline of the Left
by: Valeria Tarditi
Published: (2015-03-01)

Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
by: Valenza, Marta, et al.
Published: (2015)

Early defect of transforming growth factor β1 formation in Huntington’s disease
by: Battaglia, Giuseppe, et al.
Published: (2011)

siRNA screen identifies QPCT as a druggable target for Huntington’s disease
by: Jimenez-Sanchez, Maria, et al.
Published: (2015)

Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease
by: Vaccarino, Anthony L, et al.
Published: (2011)

Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort
by: Désaméricq, Gaëlle, et al.
Published: (2014)

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression
by: de Diego-Balaguer, Ruth, et al.
Published: (2016)

Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
by: Dobson, Lucianne, et al.
Published: (2016)

Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington’s Disease T Lymphocytes
by: Miller, James R. C., et al.
Published: (2015)

Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington’s Disease
by: Salem, Linda, et al.
Published: (2016)

Proteasome Activator Enhances Survival of Huntington's Disease Neuronal Model Cells
by: Seo, Hyemyung, et al.
Published: (2007)

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models
by: Pollock, Kari, et al.
Published: (2016)

Early atrophy of pallidum and accumbens nucleus in Huntington’s disease
by: van den Bogaard, Simon J. A., et al.
Published: (2010)

Neuropsychiatry and White Matter Microstructure in Huntington’s Disease
by: Gregory, Sarah, et al.
Published: (2015)

Congenital Corneal Anesthesia and Neurotrophic Keratitis: Diagnosis and Management
by: Mantelli, Flavio, et al.
Published: (2015)

Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease
by: Novak, Marianne J. U., et al.
Published: (2012)

Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree
by: Corrêa, Bernardo Barahona, et al.
Published: (2006)

Diagnosis and management of neurotrophic keratitis
by: Sacchetti, Marta, et al.
Published: (2014)